The Precision Peptide Company Inc. PNGAF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -207.01% | 58.76% | 58.76% | -413.65% | -114.77% |
| Total Depreciation and Amortization | -- | -- | -- | 1.83% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 976.19% | -92.09% | -66.19% | 5,288.24% | -- |
| Change in Net Operating Assets | -74.76% | -898.45% | 109.26% | -411.65% | 164.51% |
| Cash from Operations | -99.14% | -49.64% | 62.28% | -269.19% | 23.51% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 275.15% | -199.80% | -82.34% | 1,113.99% | 82.29% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 275.15% | -199.80% | -82.34% | 386.00% | 37.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -1,680.00% | 94.08% |
| Issuance of Common Stock | 104.28% | 6,396.50% | -88.95% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -99.82% | -- |
| Cash from Financing | 100.59% | 6,481.94% | -92.55% | -88.14% | 219.61% |
| Foreign Exchange rate Adjustments | -597.96% | 87.37% | -440.35% | 307.27% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 168.03% | 166.54% | 36.57% | -150.88% | 2,713.70% |